ΔSUVmax adds prognostic value to early response assessment during the first-line treatment of classical Hodgkin lymphoma: a retrospective cohort study
Altogether, ΔSUVmax is a promising standalone prognostic marker or combination partner of DS in the early risk stratification and response assessment of HL.
Authors
- Árpád Illés (ORCID: https://orcid.org/0000-0001-6548-2926)
- László Imre Pinczés (ORCID: https://orcid.org/0000-0003-0453-1709)
- Bence Farkas (ORCID: https://orcid.org/0000-0002-6328-0279)
- Zsófia Miltényi (ORCID: https://orcid.org/0000-0003-3507-9997)
- Dávid Tóthfalusi (ORCID: https://orcid.org/0009-0005-0225-3145)
- Ildikó Garai (ORCID: https://orcid.org/0000-0002-3632-431X)
- Boglárka Dobó
- Sándor Barna
Institutions
- University of Debrecen (HU)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1186/s40644-025-00904-x
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Debreceni Egyetem